We are live on
!
Find out more
KFC
Klingenstein Fields & Co Portfolio holdings
AUM
$2.86B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.14B
AUM Growth
+$140M
(+7%)
Cap. Flow
+$83.4M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
40.56%
Holding
223
New
11
Increased
84
Reduced
50
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$21.5M |
| 2 |
Merck
MRK
|
+$15.8M |
| 3 |
Weyerhaeuser
WY
|
+$15M |
| 4 |
Broadcom
AVGO
|
+$12.9M |
| 5 |
FedEx
FDX
|
+$6.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$20M |
| 2 |
ABB
ABB Ltd
ABB
|
+$13.9M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.73M |
| 4 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$2.81M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.17% |
| 2 | Communication Services | 17.11% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 14.28% |
| 5 | Consumer Staples | 12.41% |
Similar funds
AHSSHC
YC
MSDF
SAI
LIP
DMIC
PFM
AIP
Klingenstein Fields & Co's Q2 2016 Portfolio in Review
As of Q2 2016, Klingenstein Fields & Co held 223 positions worth $2.14B, up 7% from $2B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Klingenstein Fields & Co deployed $83.4M of net new capital in Q2 2016, opening 11 new positions and adding to 84 existing holdings. Its largest new stake was Broadcom: 845,850 shares worth $13.1M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was AbbVie, an estimated $20M trimmed.
- Klingenstein Fields & Co's largest Q2 2016 buy was Broadcom: 845,850 shares worth $13.1M.
- Klingenstein Fields & Co added most to CVS Health in Q2 2016, an estimated $21.5M increase.
- Klingenstein Fields & Co's biggest Q2 2016 reduction was AbbVie, cutting an estimated $20M.
- Klingenstein Fields & Co fully exited ABB Ltd in Q2 2016, selling an estimated $13.9M.
- Klingenstein Fields & Co's ten largest holdings make up 41% of its $2.14B portfolio in Q2 2016.
- Klingenstein Fields & Co opened 11 new positions and closed 12 in Q2 2016.
- Klingenstein Fields & Co's portfolio value rose 7% quarter-over-quarter to $2.14B.
Based on Klingenstein Fields & Co's 13F filing for Q2 2016, filed 1 Aug 2016.